http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106511343-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4422 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4422 |
| filingDate | 2016-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-106511343-B |
| titleOfInvention | Application of the lacidipine in the drug of preparation treatment arenavirus infection |
| abstract | The present invention provides a kind of application of lacidipine in the drug of preparation treatment arenavirus infection, belong to field of medicaments.Lacidipine can effectively inhibit arenavirus in non-toxic range and invade host cell, so as to be effectively prevented and treated the virus infection as caused by arenavirus；And the good security of lacidipine.Therefore, can further develop lacidipine is the drug for treating or preventing arenavirus infection, is with a wide range of applications.The present invention also provides a kind of application of lacidipine in the drug for the virus infection that preparation treatment is mediated by arenavirus envelope glycoprotein complex, lacidipine can act on arenavirus envelope glycoprotein complex, to effectively inhibit the virus infection mediated by arenavirus envelope glycoprotein complex.Therefore, all virus infections mediated by arenavirus envelope glycoprotein complex can effectively be treated and prevented using lacidipine. |
| priorityDate | 2016-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 354.